Clinical Trial Update: A Study of Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Pegasys (peginterferon alfa-2a) alone or with Copegus (ribavirin) in patients with chronic hepatitis C who previously partic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2013-09-04